CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Second degree atrioventricular block Mobitz type I after administration of benzathine penicillin: case report.

BACKGROUND AND OBJECTIVES: Second degree atrioventricular block Mobitz type I is seen as a transitory change in the presence of inferior wall myocardial infarction or drug intoxication. The objective of this report was to present a case of second degree atrioventricular block Mobitz type I after administration of benzathine penicillin.

CASE REPORT: The patient had a syncopal episode and sudoresis after administration of benzathine penicillin. On physical exam, he presented diaphoresis, bradycardia, and irregular heart rate. The electrocardiogram (ECG) showed second degree atrioventricular block Mobitz type I. Intravenous atropine, 0.5 mg, was administered. An ECG done one hour later was normal. The patient remained asymptomatic and, and after six hours he was discharged.

CONCLUSIONS: The patient developed second degree atrioventricular block Mobitz type I after the administration of benzathine penicillin.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app